Program Overview
Please read the following program information before accessing the presentations using links located at the bottom of this page.
Release Date: March 15, 2009 Expiration Date: March 14, 2010
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2 hours (0.2 CEUs) of continuing education credit (program number 204-000-08-464-H01P).
Methods and Format
This is an online activity consisting of audio and slides for three presentations, a post-test, and an activity evaluation tool. Participants must view all presentations, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small health systems, managed-care organizations, long-term care facilities, ambulatory clinics, outpatient pharmacies, and academia. This activity would be particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who are interested in managing hyperglycemia in hospitalized patients and coordinating their transition to ambulatory care.
Activity Content
Click here to view an overview of the activity content.Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to
- Describe the pathophysiology of type 1 and type 2 diabetes and the contributing factors that lead to hyperglycemia in hospitalized patients.
- Use morbidity, mortality, and cost data to persuade hospital staff and administrators of the benefits of managing hyperglycemia in noncritically ill patients.
- Identify at least two limitations associated with the use of sliding-scale regular insulin to manage hyperglycemia in hospitalized patients.
- Recommend an effective subcutaneous insulin protocol for managing hyperglycemia in a noncritically ill adult patient.
- Recommend appropriate drug therapy for a patient with type 2 diabetes at the time of hospital discharge.
- Explain the controversies associated with recent research pertaining to levels of glycemic control.
- Provide patient education regarding the risks and benefits of therapy and the need to reach targeted levels of glycemic control.
Faculty
Scott R. Drab, Pharm. D., CDE, BC-ADM
Program Chair
Assistant Professor of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
Director, University Diabetes Care Associates
Pittsburgh, Pennsylvania
Michelle F. Magee, M.D.
MedStar Diabetes and Research Institutes
Associate Professor of Medicine
Georgetown University School of Medicine
Washington, DC
Jennifer M. Trujillo, Pharm.D., BCPS
Associate Professor
University of Colorado Denver School of Pharmacy
Aurora, Colorado
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:Scott R. Drab, Pharm.D., CDE, BC-ADM, declares that he has served as a speaker for Merck, Novo Nordisk Inc., and Roche Laboratories Inc.; on the speakers bureau for sanofi-aventis; and as a consultant for Novo Nordisk Inc.
Michelle F. Magee, M.D., declares that she has served on the speakers bureau for Novo Nordisk Inc. and sanofi-aventis; she has also served as a consultant for and received research grants from sanofi-aventis.
Jennifer M. Trujillo, Pharm.D., BCPS, declares that she has no relationships pertinent to this activity.
Carla J. Brink, M.S., R.Ph., declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from Novo Nordisk Inc.
Launch Presentation*
Impact and Benefits of Managing Hyperglycemia in Hospitalized Patients (20 minutes)
Optimizing the Approach to Targeted Glycemic Management in the Hospital Setting (40 minutes) 
Transitioning Patients to Ambulatory Care (45 minutes)
Jennifer M. Trujillo, Pharm.D., BCPS
*Allow additional time to complete the post-test and evaluation.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
